Back to AVIR
Bain Capital Life Sciences Investors, LLC → AVIR
Bain Capital Life Sciences Investors, LLC AVIR Position History
Atea Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$10.8M
Q3 2026
Peak value
$12.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $8.9M |
| Q1 2026 | $12.7M |
| Q2 2026 | $9.7M |
| Q3 2026 | $10.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $10.8M | 2.08M | — | — |
| Q2 2026 | $9.7M | 2.08M | — | — |
| Q1 2026 | $12.7M | 2.36M | — | — |
| Q4 2025 | $8.9M | 2.49M | — | — |
Other funds holding AVIR
$50.5M
$48.9M
$40.3M
$40.2M
$38.2M
$35.2M